Cardiovascular
Product Name |
Application |
Region |
P065-Marfan-1 |
Marfan syndrome |
FBN1 15q21.1, TGFBR2 3p22 |
P066-Marfan-2 |
Marfan syndrome |
FBN1 15q21.1 |
P093-HHT/PPH1 |
Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1) |
ENG 9q34.11, ACVRL1 12q13.3, BMPR2 2q33.1-2 |
P100-MYBPC3 |
Hypertrophic cardiomyopathy, familial |
MYBPC3 11p11.2 |
P108-SCN5A |
Brugada / long QT |
SCN5A 3p22 |
P114-Long-QT |
Congenital long QT syndrome (LQT) |
KCNQ1 11p15.5, KCNH2 7q35 |
P130-CCM mix-1 |
Cerebral Cavernous Malformations (CCM) |
CCM 7q21 |
P131-CCM mix-2 |
Cerebral Cavernous Malformations (CCM) |
CCM 7q21 |
P148-TGFBR1-TGFBR2 |
Aortic aneurysm syndrome |
TGFBR1 9q22, TGFBR2 3p22 |
P168-ARVC-PKP2 |
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) |
DSP 6p24, PKP2 12q11.21 |
P180-Limb-2 |
Limb malformations, heart |
SALL1 16q12, SALL4 20q13, TBX5 12q24 |
P184-JAG1 |
Alagille Syndrome (ALGS) |
JAG1 20p12.2 |
P196-TNNT2-BAG3 |
Hypertrophic cardiomyopathy familial, Dilated cardiomyopathy |
TNNT2 1q32; BAG3 10q25 |
P234-GATA3 - GATA4 |
Cardiac septal defects |
GATA4 8p23, GATA3 10p15 |
P311-CHD |
Congenital Heart Disease (CHD) |
GATA4 8p23, NKX2-5 5q35, TBX5 12q24, BMP4 14q22, CRELD1 3p25 |
P313-CREBBP |
Rubinstein–Taybi syndrome (RSTS) |
CREBBP 16p13.3 |
P333-EP300 |
Rubinstein–Taybi syndrome (RSTS) |
EP300; 22q13.2 |
P350-CLCN1-KCNJ2 |
Myotonia congenita, Thomsen’s disease, Becker’s disease, Andersen-Tawil syndrome |
CLCN1, KCNJ2 |
P409-RASA1 |
capillary malformations, Parkes Weber syndrome |
RASA1 5q14.3 |
P418-MYH7 |
Hypertrophic cardiomyopathy |
MYH7 14q11.2 |
P434-Heterotaxy |
Heterotaxy syndrome |
ZIC3 Xq26.3, CFC1 2q21.1, ACVR2B 3p22.2, NODAL 10q22.1 |
P456-EVC EVC2 |
Ellis-van Creveld syndrome |
4p16.2 |